FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Road to Brexit
Economy
The Trump Effect
Detained in Myanmar
North Korea Revealed
Technology
Royal Wedding
Lifestyle
Healthcare
March 28, 2018 / 6:21 AM / 22 days ago

BRIEF-Diamyd Medical Q2 2017/18 Net Loss Widens To SEK 9.1 Million

Reuters Staff

1 Min Read

March 28 (Reuters) - DIAMYD MEDICAL AB:

* Q2 2017/18 NET LOSS SEK 9.1 MILLION VERSUS LOSS SEK 6.4 MILLION YEAR AGO

* Q2 2017/18 TOTAL OPERATING INCOME SEK 33,000 VERSUS SEK 60,000 YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.